In one observational study involving adults with type 2 diabetes and ischemic heart disease, tirzepatide was linked to a 40% lower risk of a composite outcome, including heart attack, stroke, and all-cause mortality (HR 0.60)
For example, MIS-C can cause myocarditis (inflammation of the heart muscle), cardiac dysfunction, liver problems, seizures and other neurologic disorders, respiratory failure, and acute kidney injury (rapid loss of kidney function)
These rebates can run from 30% to over 60% of a brand-name drugs list price, and PBMs keep a substantial portion rather than passing the full amount back to plan sponsors
BMC Biotechnol (2017) 17(1):58
View current offer and pricing here
The FDA has issued warnings about BPC-157 being found in compounded products and dietary supplements